ESMO Advanced Course on Precision Oncology in Breast Cancer Barcelona 2023

Regular price
$20.00
Sale price
$20.00
Regular price
$0
Sold out
Unit price
Quantity must be 1 or more

European Society for Medical Oncology Advanced Course on Precision Oncology in Breast Cancer Barcelona 2023

Format: 24 videos + 25 pdfs, size: 1.87 GB

Course Audience: oncologist

Overview:

Start date 09 Jun 2023

End date 10 Jun 2023

Location Barcelona, Spain

Learning objectives

  • To understand the function and biology of the most relevant driver molecular alterations in early and metastatic breast cancer
  • To gain insights in the spectrum of breast cancer molecular aberrations, platforms and strategies for molecular testing
  • To provide information and in-depth discussion on the state-of-the-art and emerging therapeutic strategies integrating major germinal or somatic mutations driving oncogene addiction in early and metastatic breast cancer
  • To present novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of metastatic breast cancer

Programme (PDF Format)

Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)

Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)

Session 1 ER Biology of the Target Biomarker (Video MP4 Format)

Session 1 ER Biology of the Target Biomarker (PDF Format)

Session 1 ESR1 Mutations Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)

Session 1 ESR1 Mutations Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)

Session 1 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (Video MP4 Format)

Session 1 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (PDF Format)

Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)

Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)

Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)

Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)

Session 2 The PI3K Pathway Insights into the Biology and Clinical Research (Video MP4 Format)

Session 2 The PI3K Pathway Insights into the Biology and Clinical Research (PDF Format)

Session 2 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for ESR1, PIK3CA and AKT (Video MP4 Format)

Session 2 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for ESR1, PIK3CA and AKT (PDF Format)

Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)

Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)

Session 3 Biology of the Target Biomarker (Video MP4 Format)

Session 3 Biology of the Target Biomarker (PDF Format)

Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (Video MP4 Format)

Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation) (PDF Format)

Session 3 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (Video MP4 Format)

Session 3 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (PDF Format)

Session 4 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (Video MP4 Format)

Session 4 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board (PDF Format)

Session 4 Biology and Testing of Biomarkers for Targeted Therapy in TNBC (Video MP4 Format)

Session 4 Biology and Testing of Biomarkers for Targeted Therapy in TNBC (PDF Format)

Session 4 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (Video MP4 Format)

Session 4 Update on the Clinical Efficacy of Targeted Agents Indications, Efficacy and Toxicity (PDF Format)

Session 4 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for PDL1, BRCA, KI67 and TILs (Video MP4 Format)

Session 4 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) for PDL1, BRCA, KI67 and TILs (PDF Format)

Session 5 HER2 Low Disease Clinical Trials and Challenges in Testing (Video MP4 Format)

Session 5 HER2 Low Disease Clinical Trials and Challenges in Testing (PDF Format)

Session 5 HER2 Pathway Testing HER2 Expression and HER2 Mutations (Video MP4 Format)

Session 5 HER2 Pathway Testing HER2 Expression and HER2 Mutations (PDF Format)

Session 5 Update on the Clinical Treatment Algorithm in HER2 Positive Disease (Early and Metastatic) (Video MP4 Format)

Session 5 Update on the Clinical Treatment Algorithm in HER2 Positive Disease (Early and Metastatic) (PDF Format)

Session 5 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) (Video MP4 Format)

Session 5 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD) (PDF Format)

Session 6 Integrating NGS in Treatment Selection for Metastatic Breast Cancer (Solid Biopsy vs ctDNA) (Video MP4 Format)

Session 6 Integrating NGS in Treatment Selection for Metastatic Breast Cancer (Solid Biopsy vs ctDNA) (PDF Format)

Session 6 Role of Genomic Assays in Early Breast Cancer (Video MP4 Format)

Session 6 Role of Genomic Assays in Early Breast Cancer (PDF Format)

Session 6 Role of Genomic Assays in Metastatic Setting A Focus on Immunotherapy (Video MP4 Format)

Session 6 Role of Genomic Assays in Metastatic Setting A Focus on Immunotherapy (PDF Format)

Welcome and Learning Objectives Introduction (Video MP4 Format)

Welcome and Learning Objectives Introduction (PDF Format)

Go to full site